Drug Shortage Report for INHIBACE PLUS
| Report ID | 230712 |
| Drug Identification Number | 02181479 |
| Brand name | INHIBACE PLUS |
| Common or Proper name | Hydrochlorothiazide / Cilazapril |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE CILAZAPRIL |
| Strength(s) | 12.5MG 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 28 tablets |
| ATC code | C09BA |
| ATC description | ACE INHIBITORS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-07-01 |
| Actual start date | |
| Estimated end date | 2024-10-20 |
| Actual end date | 2024-10-18 |
| Shortage status | Resolved |
| Updated date | 2024-10-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2024-10-19 | English | Compare |
| v8 | 2024-10-18 | French | Compare |
| v7 | 2024-10-18 | English | Compare |
| v6 | 2024-09-16 | French | Compare |
| v5 | 2024-09-16 | English | Compare |
| v4 | 2024-07-02 | English | Compare |
| v3 | 2024-06-17 | French | Compare |
| v2 | 2024-06-17 | English | Compare |
| v1 | 2024-06-17 | English | Compare |
Showing 1 to 9 of 9